產品詳情
簡單介紹：
Anti-C19orf29抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C19orf29抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C19orf29
Cat. Number:
Anti-C19orf29抗體KL-9960R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Consisting of around 63 million bases with over 1,400 genes, chromosome 19 makes up over 2% of human genomic DNA. Chromosome 19 includes a diversity of interesting genes and is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin superfamily members including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, theAnti-C19orf29抗體 CEACAM and PSG family, and Fc?receptors. Key genes for eye color and hair color also map to chromosome 19. Peutz-Jeghers syndrome, spinocerebellar ataxia type 6, the stroke disorder CADASIL, hypercholesterolemia and insulin-dependent diabetes have been linked to chromosome 19. Translocations with chromosome 19 and chromosome 14 can be seen in some lymphoproliferative disorders and typically involve the proto-oncogene BCL3. The C19orf29 gene product has been provisionally designated C19orf29 pending further characterization.
Also known as:
C19orf29; Cactin; Anti-C19orf29抗體CS029_HUMAN; FLJ17482; FLJ59622; fSAPc; Renal carcinoma antigen NY-REN-24; Uncharacterized protein C19orf29.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Cactin/C19orf29.
●
Predicted Molecular Weight: 89kDa.
Storage:
Shipped at 4℃, Anti-C19orf29抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-C19orf29抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C19orf29抗體dilutions must be determined by the end user.
kl032Mu02 白介素22(IL22)多克隆抗體 Polyclonal Antibody to Interleukin 22 (IL22)
kl033Mu02 熱休克蛋白β8(HSPβ8)多克隆抗體 Polyclonal Antibody to Heat Shock Protein Beta 8 (HSPb8)
kl034Mu02 生長分化因子15(GDF15)多克隆抗體 Polyclonal Antibody to Growth Differentiation Factor 15 (GDF15)
kl035Mu02 S100鈣結合蛋白A7(S100A7)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A7 (S100A7)
kl042Mu02 法尼酯X受體(FXR)多克隆抗體 Polyclonal Antibody to Farnesoid X Receptor (FXR)
kl042Ra01 法尼酯X受體(FXR)多克隆抗體 Polyclonal Antibody to Farnesoid X Receptor (FXR)
kl043Hu01 維甲酸X受體α(RXRα)多克隆抗體 Polyclonal Antibody to Retinoid X Receptor Alpha (RXRa)
kl043Mu01 維甲酸X受體α(RXRα)多克隆抗體 Polyclonal Antibody to Retinoid X Receptor Alpha (RXRa)
kl043Mu02 維甲酸X受體α(RXRα)多克隆抗體 Polyclonal Antibody to Retinoid X Receptor Alpha (RXRa)
kl044Mu01 肝X受體α(LXRα)多克隆抗體 Polyclonal Antibody to Liver X Receptor Alpha (LXRa)
kl044Mu02 肝X受體α(LXRα)多克隆抗體 Polyclonal Antibody to Liver X Receptor Alpha (LXRa)
kl045Mu02 存活素(Surv)多克隆抗體 Polyclonal Antibody to Survivin (Surv)
kl046Mu01 S100鈣結合蛋白A10(S100A10)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A10 (S100A10)
kl046Mu02 S100鈣結合蛋白A10(S100A10)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A10 (S100A10)
kl047Mu02 Ki-67蛋白(Ki67P)多克隆抗體 Polyclonal Antibody to Ki-67 Protein (Ki67P)
kl056Mu02 基質金屬蛋白酶14(MMP14)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)
kl058Mu01 白介素20(IL20)多克隆抗體 Polyclonal Antibody to Interleukin 20 (IL20)
kl058Mu02 白介素20(IL20)多克隆抗體 Polyclonal Antibody to Interleukin 20 (IL20)
kl058Ra01 白介素20(IL20)多克隆抗體 Polyclonal Antibody to Interleukin 20 (IL20)
